Zobrazeno 1 - 10
of 1 757
pro vyhledávání: '"Huang Sm"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 5085-5090 (2023)
Su-Fei Pan,* Shi-Mei Huang,* Lian Xie, Yuan-Yuan Zhang, Yu-Rong Tang, Xiao-Zhen Wang Department of Clinical Laboratory, Shengli Oilfield Central Hospital, Dongying, People’s Republic of China*These authors contributed equally to this wo
Externí odkaz:
https://doaj.org/article/39f499620ec44f07bd805222c087c39b
Assessing the Global Impact on the Mouse Kidney After Traumatic Brain Injury: A Transcriptomic Study
Publikováno v:
Journal of Inflammation Research, Vol Volume 15, Pp 4833-4851 (2022)
Wei-Hung Chan,1,2 Yu-Juei Hsu,3 Chiao-Pei Cheng,1 Kuan-Nien Chou,2,4 Chin-Li Chen,5 Shih-Ming Huang,6 Wei-Chih Kan,7,8,* Yi-Lin Chiu6,* 1Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei City,
Externí odkaz:
https://doaj.org/article/1aff4921ca9a45398aa93afaa1614c84
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 6567-6579 (2019)
Chun-Lin Kuo,1 Shu-Man Hsieh Li,*,2 Shu-Yi Liang,*,2 Shu-Ting Liu,2 Li-Chun Huang,2 Wei-Ming Wang,3 Li-Chen Yen,2,4 Shih-Ming Huang21Department of Orthopaedic Surgery, Tri-Service General Hospital, National Defense Medical Center, Taiwan, Republic of
Externí odkaz:
https://doaj.org/article/d2130c6cf4b44b488cb63d9897edc5d8
Publikováno v:
OncoTargets and Therapy, Vol Volume 15, Pp 159-164 (2022)
Lei-Si Zhang,1,2,* Jun Wang,1,2,* Ming-Zhu Xu,1,2,* Tian-Mei Wu,1,2 Si-Man Huang,1,2 Han-Yu Cao,1,2 Ai-Ning Sun,1,2 Song-Bai Liu,3 Sheng-Li Xue1,2 1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematolog
Publikováno v:
OncoTargets and Therapy, Vol Volume 14, Pp 4345-4359 (2021)
Siou-Min Luo,1 Yi-Ping Wu,2 Li-Chun Huang,2 Shih-Ming Huang,1,2 Dueng-Yuan Hueng1– 3 1Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China; 2Department of Biochemistry, National Defense Medical
Publikováno v:
The AAPS journal. 22(1)
Bioanalysis in biosimilar biological product development (BPD) plays a critical role in demonstrating pharmacokinetic (PK) similarity across products. The 2018 FDA Bioanalytical Method Validation guidance for industry provides general principles in t
Autor:
Chi Kuan Chen, Jang-Ming Lee, Michael Hsiao, Tsu-Yao Cheng, Kuo Tai Hua, Yi Chieh Yang, Huang Sm, Chia Yi Su, Pei Wen Yang, M L Kuo
Publikováno v:
Europe PubMed Central
Secondary mutation of epidermal growth factor receptor (EGFR) resulting in drug resistance is one of the most critical issues in lung cancer therapy. Several drugs are being developed to overcome EGFR tyrosine kinase inhibitor (TKI) resistance. Here,
Autor:
Huang Sm, Brian Smith
Publikováno v:
Clinical Pharmacology & Therapeutics. 97:196-199
Publikováno v:
Clinical pharmacology and therapeutics, vol 103, iss 3
Hsueh, C-H; Hsu, V; Zhao, P; Zhang, L; Giacomini, KM; & Huang, S-M. (2018). PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters. CLINICAL PHARMACOLOGY & THERAPEUTICS, 103(3), 485-492. doi: 10.1002/cpt.750. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/96t7w90t
Hsueh, C-H; Hsu, V; Zhao, P; Zhang, L; Giacomini, KM; & Huang, S-M. (2018). PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters. CLINICAL PHARMACOLOGY & THERAPEUTICS, 103(3), 485-492. doi: 10.1002/cpt.750. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/96t7w90t
Altered pharmacokinetics (PK) in subjects with chronic kidney disease (CKD) may lead to dosing adjustment of certain drugs in subjects with CKD. It can be valuable to quantitatively predict PK in CKD for the management of drug dosing in these subject
Publikováno v:
Clinical Pharmacology and Therapeutics